Potential role of polymorphisms in the transporter genes ENT1 and MATE1/OCT2 in predicting TAS-102 efficacy and toxicity in patients with refractory metastatic colorectal cancer.
暂无分享，去创建一个
A. Barzi | H. Lenz | S. Okazaki | Dongyun Yang | Wu Zhang | F. Loupakis | Toshiharu Yamaguchi | V. Dadduzio | F. Pietrantonio | Y. Miyamoto | M. D. Berger | S. Cao | L. Salvatore | Y. Ning | M. Schirripa | B. Borelli | M. Suenaga | R. Gopez